BioSpace News Archive

Lone Star Bio

Lantern Pharma Receives Notice of US Patent Allowance for Drug Candidate LP-184 for the Treatment of Rare Pediatric Brain Cancer, ATRT

Lantern Pharma Inc. received a notice of allowance from the United States Patent and Trademark Office (USPTO) covering a method of treatment for Atypical Teratoid Rhabdoid Tumor (ATRT) using LP-184, an aggressive and rapidly growing form of cancer of the central nervous system (CNS).

August 14, 2023
·
8 min read
Business

Virpax Pharmaceuticals Reports 2023 Second Quarter Results and Recent Developments

Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX) today announced its financial results for the three months ended June 30, 2023, and other recent developments.

August 14, 2023
·
12 min read
Business

Vaso Corporation Announces Financial Results for Second Quarter 2023

Vaso Corporation (“Vaso”) (OTCQB:VASO) today reported its operating results for the three months ended June 30, 2023.

August 14, 2023
·
6 min read
Business

IGC Pharma Reports First Quarter Results; Company Continues to Make Significant Progress Advancing Its Lead Alzheimer’s Candidate Through Phase 2 Clinical Trials

IGC Pharma, Inc. (“IGC” or the “Company”) (NYSE American: IGC) today announced its financial results for the quarter ended June 30, 2023, which is the first quarter of the Company’s 2024 fiscal year.

August 14, 2023
·
7 min read
Biotech Beach

GeneTex Addresses GPCR Targets With Its Recombinant Monoclonal Antibody Production Platform

GeneTex, a multinational antibody manufacturing company, is leveraging its recombinant monoclonal antibody production platform and augmented validation protocols to generate immunological reagents against high-value targets that have historically proven difficult to produce.

August 14, 2023
·
3 min read
Pharm Country

Neuronetics Revolutionizes Patient Communication and Provider Support Through Its Exclusive TrakStar® Platform

Neuronetics, Inc. announced enhancements to the TrakStar® Patient Data Management System, a proprietary, HIPAA-compliant, patient management and outcomes reporting system for NeuroStar transcranial magnetic stimulation providers.

August 14, 2023
·
3 min read
Business

Solve GNE and Genosera Sign Agreement to Develop a Novel Bicistronic AAV Gene Therapy Targeting HIBM

Solve GNE announced today that it has entered into a sponsored research agreement with Genosera to provide funding for a novel Adeno-Associated Virus (AAV) gene therapy aimed at curing GNE Myopathy (GNEM) or Hereditary Inclusion Body Myopathy (HIBM).

August 14, 2023
·
3 min read
Genetown

binx health Announces Time and Motion Study Data Shared at STI & HIV 2023 World Congress in Chicago, IL

binx health announced new data shared at the STI & HIV 2023 World Congress in a poster session entitled: Clinic-Based Hands-On Time and Time-to-Result for Point of Care Chlamydia and Gonorrhea Test Compared to Laboratory Based Test.

August 14, 2023
·
3 min read
Zealand Pharma Hosts Conference Call on August 17 at 2pm CET (8am ET) to Present First Half 2023 Results

a Zealand Pharma A/S, a biotechnology company focused on the discovery and development of innovative peptide-based medicines, announced that it will host a conference call on August 17, 2023, at 2:00 pm CET following the announcement of results for the second quarter and first half of 2023.

August 14, 2023
·
1 min read
Business

IMUNON Expands Scientific Advisory Board with the Addition of Dr. Sachet Shukla

IMUNON, Inc. announces the addition of Sachet A. Shukla, Ph.D. to the company’s scientific advisory board (SAB).

August 14, 2023
·
5 min read